Answers · Views and frameworks
Where do the US and China diverge in AI in 2026?
FutureX Capital's judgment: in 2026 the US and China sit at different points of one AI cycle, the US late in its mania phase and China early to mid, so they cannot run on one clock.
FutureX reads it as a mismatch table with three rows. Funding: in Q1 2026 three companies took 67.3% of US AI funding, while 64.6% of China's went to early rounds. Exits: no AI company listed in the US that quarter; 155 Chinese companies went public in the first half. Openness: the US runs mostly closed models under power and packaging constraints; China leads open source with 45%-plus of OpenRouter traffic. Concentration spreading from funding to exits holds only in the US.
The money gap is about 14x: US AI venture investment was $194 billion in 2025 against $14 billion in China (PitchBook/NVCA/CAICT, confirmed). In a16z's August 2025 ranking, 44% of the global top 50 AI apps came from Chinese teams, valued at about a third of US comparables (reported).
For a founder, the mismatch means this: the new wave of global AI companies puts Chinese engineering density and global pricing inside one company, bills in dollars, earns more than half its revenue overseas, and closes the valuation discount itself. FutureX, founded in Asia in 2018 and headquartered in Hong Kong with 8 offices including Shanghai, Shenzhen, Singapore and Silicon Valley, invests in both dollars and RMB and looks for exactly these teams building across two cycles.
As of August 2026, Cognition is valued at $26 billion with ARR above $490 million, and Manus has ARR above $100 million (reported). Per company disclosure, FutureX-backed Genspark reached $200 million ARR in 11 months, and Dify earns 57% of its revenue overseas.
Report · US-China AI Primary Market Capital Flows: H1 2026 →Report · China AI Going Global 2026: Open-Source Breakout and the Global Race (Mid-July Update) →Deck · Open Source Breaks the Deadlock →
Related answers
Updated 2026-09-15. Facts and examples come from FutureX Capital's published research, public talks, and public reporting, graded per our site-wide standard (verified / reported / per company disclosure). Nothing here is investment advice or an offer.